Clover Health Investments, Corp. (NASDAQ:CLOV) Position Boosted by Jaffetilchin Investment Partners LLC

Jaffetilchin Investment Partners LLC increased its holdings in Clover Health Investments, Corp. (NASDAQ:CLOVFree Report) by 30.2% in the first quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 49,741 shares of the company’s stock after buying an additional 11,550 shares during the quarter. Jaffetilchin Investment Partners LLC’s holdings in Clover Health Investments were worth $39,000 at the end of the most recent reporting period.

Other institutional investors and hedge funds have also added to or reduced their stakes in the company. Jupiter Asset Management Ltd. grew its holdings in Clover Health Investments by 18.1% in the 1st quarter. Jupiter Asset Management Ltd. now owns 4,525,079 shares of the company’s stock worth $3,593,000 after buying an additional 692,878 shares in the last quarter. Jump Financial LLC bought a new position in Clover Health Investments during the 4th quarter valued at $125,000. Turtle Creek Wealth Advisors LLC bought a new position in Clover Health Investments during the 4th quarter valued at $162,000. SignalPoint Asset Management LLC boosted its stake in Clover Health Investments by 40.3% during the 1st quarter. SignalPoint Asset Management LLC now owns 139,366 shares of the company’s stock valued at $111,000 after purchasing an additional 40,000 shares in the last quarter. Finally, Allspring Global Investments Holdings LLC boosted its stake in Clover Health Investments by 151.2% during the 1st quarter. Allspring Global Investments Holdings LLC now owns 77,948 shares of the company’s stock valued at $62,000 after purchasing an additional 46,912 shares in the last quarter. 19.77% of the stock is owned by institutional investors.

Clover Health Investments Stock Down 7.2 %

NASDAQ CLOV traded down $0.13 on Friday, reaching $1.67. 3,975,471 shares of the stock traded hands, compared to its average volume of 7,404,852. The firm’s fifty day simple moving average is $1.33 and its 200 day simple moving average is $1.01. The company has a market cap of $829.05 million, a price-to-earnings ratio of -5.29 and a beta of 2.09. Clover Health Investments, Corp. has a 12 month low of $0.61 and a 12 month high of $1.97.

Clover Health Investments (NASDAQ:CLOVGet Free Report) last issued its quarterly earnings results on Tuesday, May 7th. The company reported ($0.05) earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of ($0.07) by $0.02. The firm had revenue of $346.92 million during the quarter, compared to analyst estimates of $316.10 million. Clover Health Investments had a negative return on equity of 48.07% and a negative net margin of 8.63%. As a group, equities research analysts forecast that Clover Health Investments, Corp. will post -0.21 EPS for the current fiscal year.

Clover Health Investments Profile

(Free Report)

Clover Health Investments, Corp. provides medicare advantage plans in the United States. It operates through two segments: Insurance and Non-Insurance. It also offers Clover Assistant, a cloud-based software platform, that enables physicians to detect, identify, and manage chronic diseases earlier; and access to data-driven and personalized insights for the patients they treat.

Read More

Want to see what other hedge funds are holding CLOV? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Clover Health Investments, Corp. (NASDAQ:CLOVFree Report).

Institutional Ownership by Quarter for Clover Health Investments (NASDAQ:CLOV)

Receive News & Ratings for Clover Health Investments Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clover Health Investments and related companies with MarketBeat.com's FREE daily email newsletter.